(Q40959633)

English

Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study

scientific article published on 9 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study (English)

1 reference

Europe PubMed Central

25 September 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

2

object named as

Nayoung Kim

1 reference

Europe PubMed Central

25 September 2017

author name string

Yong Hwan Kwon

1

1 reference

Europe PubMed Central

25 September 2017

Ju Yup Lee

3

1 reference

Europe PubMed Central

25 September 2017

Yoon Jin Choi

4

1 reference

Europe PubMed Central

25 September 2017

Kichul Yoon

5

1 reference

Europe PubMed Central

25 September 2017

Ryung Hee Nam

6

1 reference

Europe PubMed Central

25 September 2017

Ji Hyung Suh

7

1 reference

Europe PubMed Central

25 September 2017

Jung Won Lee

8

1 reference

Europe PubMed Central

25 September 2017

Dong Ho Lee

9

1 reference

Europe PubMed Central

25 September 2017

publication date

9 October 2015

1 reference

Europe PubMed Central

25 September 2017

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

25 September 2017

51

1 reference

Europe PubMed Central

25 September 2017

3

1 reference

Europe PubMed Central

25 September 2017

270-276

1 reference

Europe PubMed Central

25 September 2017

Helicobacter pylori and gastric cancer: factors that modulate disease risk

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Antibiotic resistance problems with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Changes in Antibiotic Susceptibility of Helicobacter pylori in the Course of Eight Years in the Zaanstreek Region in The Netherlands

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Culture-guided treatment approach for Helicobacter pylori infection: review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Efficacy of a multistep strategy for Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Helicobacter pylori therapy demystified

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1095352

21 January 2018

Identifiers

10.3109/00365521.2015.1095352

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40959633&oldid=1911227482"